Image

Extended Bolus for Meals in a Closed-loop System

Extended Bolus for Meals in a Closed-loop System

Recruiting
13-19 years
All
Phase 4

Powered by AI

Overview

This study aims to evaluate whether the use of an extended bolus will improve glucose control with high-fat high protein meals using a closed-loop system. The new knowledge gained from this study may provide a method to allow for the proper administration of insulin over an extended period to mitigate the risk of prolonged hyperglycemia or early hypoglycemia.

Eligibility

Inclusion Criteria

  • Age between 13 and 19 years old, A1C > 6% at screening
  • Diagnosed with type 1 diabetes for at least one year
  • Total daily dose (TDD) of insulin ≥ 0.3 units/kg/day
  • Currently using the Control IQ closed-loop system
  • Willing to abide by meal recommendations and study procedures
  • Willing and able to sign the Informed Consent Form (ICF) and/or has a parent or guardian willing and able to sign the ICF
  • Use an Android or Apple smartphone
  • Willingness not to start any new non-insulin glucose-lowering agent during the course of the trial
  • Participant and parent(s)/guardian(s) willingness to participate in all training sessions as directed by study staff
  • Parent/guardian proficient in reading and writing English
  • Live in the United States, with no plans to move outside the United States during the study period

Exclusion Criteria

  • A1C >10%
  • One or more episodes of severe hypoglycemia or DKA requiring ER visit or hospitalization within the past three months
  • Used non-insulin anti-diabetic medication within the last 30 days other than metformin
  • Known history of gastroparesis, seizure disorder, adrenal insufficiency, or ongoing renal or hepatic disease
  • Pregnancy or lactation
  • Untreated or unstable hypothyroidism
  • Currently undergoing cancer treatment or systemic treatment with steroids
  • Untreated or inadequately treated mental illness
  • Current alcohol abuse
  • Current illness that would interfere with participation in the study
  • Delayed gastric emptying or any concurrent conditions that can be associated with delayed gastric emptying or altered digestion; and the use of any medication that affects gastric emptying
  • Celiac Disease

Study details
    Type 1 Diabetes

NCT05454891

University of California, San Francisco

16 April 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.